medigraphic.com
SPANISH

Revista de Investigación Clínica

Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán
  • Contents
  • View Archive
  • Information
    • General Information        
    • Directory
  • Publish
    • Instructions for authors        
  • medigraphic.com
    • Home
    • Journals index            
    • Register / Login
  • Mi perfil

2018, Number 3

Next >>

Rev Invest Clin 2018; 70 (3)

Nutrition in Patients with Cancer Treated with Chemo-radiotherapy to the Abdominopelvic Area. A consensus report

Cetina-Pérez L, Castro-Eguiluz D, Oñate-Ocaña LF
Full text How to cite this article

Language: English
References: 13
Page: 109-111
PDF size: 62.05 Kb.


Key words:

No keywords

Text Extraction

Cancer is recognized as a public health problem affecting children, adults, and the elderly. Overall, 14.1 million new cancer cases and 8.2 million deaths were due to cancer in 20121. In Mexico, cancer is the second cause of death. The most frequent cancer tumors in men are prostate, lung, and stomach; in women, the most frequent are breast, uterine cervix, and liver2. The aim of cancer treatment is to cure the disease or considerably prolong survival while maintaining the patient’s quality of life. Treatment involves three main approaches: surgery, radiotherapy, or chemotherapy, and these may be combined according to each patient’s requirements.


REFERENCES

  1. Ferlay J, Soerjomataram I, Dikshit R, et al. Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012: globocan 2012. Int J Cancer. 2015;136:E359.

  2. Ríos PR, Rivera AG, Cervantes FS, Martínez PM. Tendencia de la mortalidad por cáncer en México: 1990-2012. Evid Méd Investig Salud. 2015;8:5-15.

  3. Andreyev J. Gastrointestinal complications of pelvic radiotherapy: are they of any importance? Gut. 2005;54:1051-4.

  4. Gami B, Harrington K, Blake P, et al. How patients manage gastrointestinal symptoms after pelvic radiotherapy. Aliment Pharmacol Ther. 2003;18:987-94.

  5. Andreyev HJ. Gastrointestinal problems after pelvic radiotherapy: the past, the present and the future. Clin Oncol. 2007;19:790-9.

  6. Hauer-Jensen M, Denham JW, Andreyev HJ. Radiation enteropathy- pathogenesis, treatment and prevention. Nat Rev Gastroenterol Hepatol. 2014;11:470-9.

  7. Coia LR, Myerson RJ, Tepper JE. Late effects of radiation therapy on the gastrointestinal tract. Int J Radiat Oncol Biol Phys. 1995;31:1213-36.

  8. Bentzen SM. Preventing or reducing late side effects of radiation therapy: radiobiology meets molecular pathology. Nat Rev Cancer. 2006;6:702-13.

  9. Henson CC, Burden S, Davidson SE, Lal S. Nutritional interventions for reducing gastrointestinal toxicity in adults undergoing radical pelvic radiotherapy. Cochrane Database Syst. 2013; 11:CD009896.

  10. McGough C, Baldwin C, Frost G, Andreyev HJ. Role of nutritional intervention in patients treated with radiotherapy for pelvic malignancy. Br J Cancer. 2004;90:2278-87.

  11. Atkins D, Best D, Briss PA, et al. Grading quality of evidence and strength of recommendations. BMJ. 2004;328:1490.

  12. Sanabria AJ, Rigau D, Rotaeche R, Selva A, Marzo-Castillejo M, Alonso-Coello P. Sistema GRADE: metodología para la realización de recomendaciones para la práctica clínica. Atención Primaria. 2015;47:48-55.

  13. Oñate-Ocaña LF, Ochoa-Carrillo FJ. Sistema GRADE para clasificar nivel de evidencia y grado de las recomendaciones para la elaboración de guías de buena práctica clínica. Cir Cir. 2009; 77:417-9.




2020     |     www.medigraphic.com

Mi perfil

C?MO CITAR (Vancouver)

Rev Invest Clin. 2018;70